Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates - Mineola /ID# 269534 — Mineola, New York

Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates - Mineola /ID# 269534 is a clinical research site located in Mineola, New York, United States 11501.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates - Mineola /ID# 269534 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates - Mineola /ID# 269534?

Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates - Mineola /ID# 269534 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates - Mineola /ID# 269534 conducted?

Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates - Mineola /ID# 269534 has 1 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Is Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates - Mineola /ID# 269534 accredited by Crixeo Health?

Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates - Mineola /ID# 269534 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates - Mineola /ID# 269534?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.